switch to tirzepatide from semaglutide Switching not losing weight on semaglutide

doi:10.1124/pr.115.011395 Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM

Specific Focus: Individuals can address targeted concerns, such as improving cognitive function with glycine or combating oxidative stress with NAC, based on their unique health priorities

This decentralization has created a patchwork of policies: some states cover GLP-1s for diabetes only, others for both diabetes and obesity, and a few restrict coverage to specific patient populations or BMI thresholds

3 These findings move GLP-1s out of the weight-loss drug category and into the category of proven cardiovascular risk-reduction tools

Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity

A Common Question We Hear This question comes up a lot, often from people thinking they can extend the shelf life indefinitely